Rich Carney, CFA

Research Analyst
Rich Carney, CFA | Janus Henderson Investors

Rich Carney is a Research Analyst at Janus Henderson Investors primarily focused on companies in the Health Care sector. Prior to joining Janus in 2015, Rich was a portfolio manager for Gerlach, Way, Scarth & Associates, where he managed high-net-worth portfolios. Previously, he was a partner and portfolio manager/analyst at Platte River Capital responsible for co-managing an equity portfolio as the lead analyst in the health care and financial services sectors. Rich’s experience also includes serving as a research analyst at The Boston Company, Silvergate Capital Management, and Invesco.

Rich received his bachelor of arts degree in economics from Rutgers University and a master of science degree in finance from Northeastern University. He holds the Chartered Financial Analyst designation and has 26 years of financial industry experience.

Articles Written

Affordable Care Act: “Reports of My Death Are Greatly Exaggerated”

Affordable Care Act: “Reports of My Death Are Greatly Exaggerated”

A look at the future of the ACA following the passing of Supreme Court Justice Ruth Bader Ginsburg and what it means for health care stocks.

COVID-19: Understanding the Science & Investment Implications (Part IV)

COVID-19: Understanding the Science & Investment Implications (Part IV)

The search for an effective COVID-19 treatment is gaining momentum, with public and private entities partnering to speed the process. In this fourth installment on the scientific and investment implications of COVID-19, Portfolio Manager and Research Analyst Dan Lyons explains the latest drug developments, as well as whether the U.S. can meet aggressive testing goals to reopen the economy.

COVID-19: Understanding the Science & Investment Implications (Part III)

COVID-19: Understanding the Science & Investment Implications (Part III)

In the third installment of our series on the scientific and investment implications of COVID-19, Health Care Analyst Rich Carney discusses how the health care system has responded to the crisis, how federal and private funding has factored into that response, and why certain emerging trends in the sector, such as telemedicine, will likely accelerate post-pandemic.

COVID-19: Understanding the Science & Investment Implications (Part III)

COVID-19: Understanding the Science & Investment Implications (Part III)

A new video series from our health care team offers unique insight into the scientific and investment implications of the COVID-19 crisis.

Health Care Reform that Could Lower Costs
Quick Views Healthcare

Health Care Reform that Could Lower Costs

Amid a raft of costly proposals to overhaul U.S. health care, companies are hustling to find efficiencies and improve patient outcomes.